Literature DB >> 21928413

Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx.

José F Carrillo1, Federico Maldonado, Liliana C Carrillo, Margarita C Ramirez-Ortega, Juan G Gómez Pizano, C Melo, José G Chanona, K Luna-Ortiz, Luis F Oñate Ocaña.   

Abstract

BACKGROUND: This study was performed to define prognostic factors and management of minor salivary gland carcinoma of the oral cavity and oropharynx .
METHODS: Retrospective analyses of patients with salivary gland carcinoma of the oral cavity or oropharynx, treated in 1989 to 2006. Statistics included univariate analyses to identify prognostic factors associated with disease-free survival (DFS) and disease-specific survival. A multivariate analysis model was constructed by the Cox method.
RESULTS: Seventy-seven patients constituted our cohort. Significant prognostic factors regarding DFS and disease-specific survival in univariate analyses comprised tumor size, surgical margins, grade, lymph node status, and Karnofsky status and T classification. A multivariate model identified tumor size, grade, surgical margins, and lymph node status significant regarding DFS.
CONCLUSIONS: Tumor size, grade, surgical margins, and lymph node status could be used for a rational design of treatment strategies in these rare tumors.
Copyright © 2010 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2010        PMID: 21928413     DOI: 10.1002/hed.21641

Source DB:  PubMed          Journal:  Head Neck        ISSN: 1043-3074            Impact factor:   3.147


  8 in total

1.  The prognostic significance of β-catenin, cyclin D1 and PIN1 in minor salivary gland carcinoma: β-catenin predicts overall survival.

Authors:  Sven Schneider; Dietmar Thurnher; Rudolf Seemann; Markus Brunner; Lorenz Kadletz; Bahil Ghanim; Klaus Aumayr; Gregor Heiduschka; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-03-24       Impact factor: 2.503

2.  Prognostic factors and occult nodal disease in mucoepidermoid carcinoma of the oral cavity and oropharynx: An analysis of the National Cancer Database.

Authors:  Mark A Ellis; Evan M Graboyes; Terry A Day; David M Neskey
Journal:  Oral Oncol       Date:  2017-07-27       Impact factor: 5.337

3.  Minor salivary gland carcinoma: a review of 35 cases.

Authors:  Georg Haymerle; Sven Schneider; Luke Harris; Theresia Häupl; Christian Schopper; Johannes Pammer; Matthaeus Ch Grasl; Boban M Erovic
Journal:  Eur Arch Otorhinolaryngol       Date:  2015-10-23       Impact factor: 2.503

4.  CD44/CD24 immunophenotypes on clinicopathologic features of salivary glands malignant neoplasms.

Authors:  Danilo Figueiredo Soave; João Paulo Oliveira da Costa; Giorgia Gobbi da Silveira; Renata Carolina Fraga Ianez; Lucinei Roberto de Oliveira; Silvia Vanessa Lourenço; Alfredo Ribeiro-Silva
Journal:  Diagn Pathol       Date:  2013-02-18       Impact factor: 2.644

5.  Transoral endoscopic head and neck surgery (eHNS) for minor salivary gland tumors of the oropharynx.

Authors:  David W Schoppy; Michael E Kupferman; Amy C Hessel; Diana M Bell; Elizabeth M Garland; Edward J Damrose; F Christopher Holsinger
Journal:  Cancers Head Neck       Date:  2017-05-31

6.  Mucoepidermoid carcinoma of the tongue base mimicking an ectopic thyroid.

Authors:  Salvatore Martellucci; Giulio Pagliuca; Marco de Vincentiis; Chiara Rosato; Ettore Scaini; Camilla Gallipoli; Andrea Gallo
Journal:  Case Rep Otolaryngol       Date:  2013-02-07

Review 7.  Polymorphous low-grade adenocarcinoma: an analysis of epidemiological studies and hints for pathologists.

Authors:  Vera Cavalcanti de Araujo; Fabricio Passador-Santos; Cecilia Turssi; Andresa Borges Soares; Ney Soares de Araujo
Journal:  Diagn Pathol       Date:  2013-01-15       Impact factor: 2.644

8.  ELMO3 - a Negative Prognostic Marker in Minor Salivary Gland Carcinoma.

Authors:  Ulana Kotowski; Lorenz Kadletz; Sven Schneider; Felicitas Oberndorfer; Boban M Erovic; Matthaeus Ch Grasl; Claudia Lill; Gregor Heiduschka
Journal:  Pathol Oncol Res       Date:  2018-10-29       Impact factor: 3.201

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.